Literature DB >> 24687396

Continuous outpatient terlipressin infusion for hepatorenal syndrome as a bridge to successful liver transplantation.

Marcus Robertson1, Avik Majumdar, Kent Garrett, Greg Rumler, Paul Gow, Adam Testro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24687396     DOI： 10.1002/hep.27154

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].

Authors:  K Lenz; R Buder; G Lohr; P Piringer; M Voglmayr
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

2.  Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Eng-Loon Tng; Mario Csenar; Neil Hawkins; Chavdar S Pavlov; Brian R Davidson; Douglas Thorburn; Maxine Cowlin; Elisabeth Jane Milne; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2019-09-12

Review 3.  Acute Kidney Injury in Patients with Cirrhosis.

Authors:  Kirk B Russ; Todd M Stevens; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

4.  An investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndrome.

Authors:  Thi Ngoc Nhieu Bui; Su Sandar; Giuseppe Luna; Jasmine Beaman; Bruce Sunderland; Petra Czarniak
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.